(Q52298136)

28 April 2018

MDMA

0 references

title

Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users. (English)

1 reference

28 April 2018

author

Jason M. White

4

1 reference

28 April 2018

author name string

Kate M Morefield

1

1 reference

28 April 2018

Michael Keane

2

1 reference

28 April 2018

Peter Felgate

3

1 reference

28 April 2018

Rodney J Irvine

5

1 reference

28 April 2018

language of work or name

English

0 references

publication date

3 May 2011

1 reference

28 April 2018

published in

Addiction

1 reference

28 April 2018

volume

106

1 reference

28 April 2018

issue

7

1 reference

28 April 2018

page(s)

1293-1300

1 reference

28 April 2018

MDMA (ecstasy) and the rave: a review

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Patterns of ecstasy use in Australia: findings from a national household survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Underground pill testing, down under

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Ecstasy: are animal data consistent between species and can they translate to humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

MDMA use and neurocognition: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Neurotoxic effects of ecstasy on the thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

The content of ecstasy tablets: implications for the study of their long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Plasma drug concentrations and physiological measures in 'dance party' participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

The health effects of ecstasy: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Pharmacological content of tablets sold as "ecstasy": results from an online testing service

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

MDMA: on the translation from rodent to human dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

The subjective effects of MDMA and mCPP in moderate MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Ecstasy pill testing: harm minimization gone too far?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

MDMA misrepresentation: an unresolved problem for Ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

Polydrug use at raves by a Western Australian sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03399.X

10.1111/J.1360-0443.2011.03399.X

21 January 2018

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018